Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,236.42
+42.101.32%
Number of Gainers:18
Number of Losers:11
Number of Flat:2
PE:- -
High:3,260.68
Open:3,195.34
Low:3,195.34
Close:3,194.32
Volume:404.56M
Turnover:53.61B
Market Cap:6.14T
Float Cap:5.42T

Loading ...

Microsoft Stock Outlook: Azure Growth and New Copilot Features Face a $50 Billion Spending Test

TradingKey
·
Sep 28

Citi expanding digital-asset footprint with Coinbase partnership, WSJ reports

TIPRANKS
·
Sep 28

JPMorgan Increases Stake in CFMEE (09630) by 10,950 Shares at Approximately HK$366.7 Each

Stock News
·
Sep 28

Coinbase price target raised to $205 from $130 at Baird

TIPRANKS
·
Sep 28

Eli Lilly price target raised to $1,500 from $1,400 at JPMorgan

TIPRANKS
·
Sep 28

Citigroup Has Tapped Coinbase to Help the Bank’s Large Corporate Clients Accept Stablecoin Payments from Customers - WSJ

THOMSON REUTERS
·
Sep 28

Merck in License Pact Worth up to $2.13 Billion with SciBrunch Therapeutics

Dow Jones
·
Sep 28

JPMorgan Trims Stake in China Suntien Green Energy by 2.675 Million Shares at About HK$3.38 Each

Stock News
·
Sep 28

Market Chatter: General Motors CFO Warns of Potential Increase in US Competition

MT Newswires Live
·
Sep 28

Oracle vs. Nvidia: Insiders Sell These 2 Tech Stocks — One Offers 80% Upside

TIPRANKS
·
Sep 28

Lilly Launches Initiative to Expand Diabetes, Obesity Drug Access

MT Newswires Live
·
Sep 28

GXO Logistics Appoints Dan Davis President of Aerospace and Defense Unit

Reuters
·
Sep 28

Eli Lilly launches ‘Lilly Change the Course Commitment’

TIPRANKS
·
Sep 28

Merck enters global license agreement with SciBrunch Therapeutics for SPR2015

TIPRANKS
·
Sep 28

Analysts’ Top Technology Picks: Full Truck Alliance (YMM), Microsoft (MSFT)

TIPRANKS
·
Sep 28

Merck Enters into Exclusive Global License Agreement with Scibrunch Therapeutics for Spr2015, an Investigational Oral Kras G12d (On) Inhibitor

Reuters
·
Sep 28

Eli Lilly - to Register Diabetes and Obesity Medicines in Lmics and Expand Access

THOMSON REUTERS
·
Sep 28

Eli Lilly - Aims to Treat Equal Number of Patients in Lmics and High-Income Countries by 2040

THOMSON REUTERS
·
Sep 28

Merck & Co - to Record $400 Mln Pre-Tax Charge, $0.13 Per Share, in Q3 2026

THOMSON REUTERS
·
Sep 28

Merck & Co - Deal Includes $400 Mln Upfront, Total Potential Value $2.13 Bln; Deal Closed

THOMSON REUTERS
·
Sep 28